IRCT20200105046010N26招募中未知
In- Vivo Bioequivalence study of Lenalidomide cap. 25mg Sobhan Oncology (LENASOB® 25mg) with brand drug (REVLIMID® 25mg Colgene, Bristol-Myers Squibb) in Iranian healthy volunteers
SOBHAN ONCOLOGY Pharmaceutical0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health(liver, heart, kidney)
- •Body mass index(18-28)
- •Informed consent
- •Age(18-60)
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
尚未招募
不适用
enalidomide tablet 25mg ABIDI (MYLODEQ® 25mg), In-Vivo Bioequivalence in iranian healthy volunteer, In-Vivo Bioequivalence in iranian healthy volunteerIn this study the bioequivalence of test and brand of Lenalidomide tablet will evaluated..IRCT20200105046010N6Tabriz University of Medical Sciences24
招募中
不适用
In-vivo Bioequivalence Test of Linalidomide capsules with brand drug (REVLIMID® 25 mg, Celgene, Bristol-Myers Squibb, UK)IRCT20200105046010N53Actero middle east Pharm. Co.24
招募中
Unknown
Investigating the in vivo bioequivalence of Indapamide 1.5 mg tabletIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N65Tabriz University of Medical Sciences24
招募中
不适用
evetiracetam tablet 1000mg (LEVEBEL 1000mg, Cobel Darou) In- Vivo Bioequivalence study in Iranian healthy volunteersin this study the bioequivalence of test and brand of levetiracetam will evaluated..IRCT20200105046010N1Cobel Darou Pharmaceutical Company24
终止
1 期
A Phase Ib study of lenalidomide in combination with imatinib for adult patients with chronic myeloid leukaemia in second molecular remissioACTRN12615001169538South Australian Health & Medical Research Institute (SAHMRI)3